Please click here to The 2 nd

1
SCIENTIFIC SECRETARIAT
TURKISH ASSOCIATION OF HEPATO BILIO PANCREATOLOGY
Dr. Mediha Eldem Sok. No:68/8 Ankara / Turkey
Phone : +90 312 435 69 92
E-Mail : [email protected]
ORGANIZATION SECRETARIAT
FTS TOURISM CONGRESS ORGANIZATION
Phone : +90 312 439 68 04 / Fax : +90 312 439 68 02
E-Mail : [email protected]
www.ftskongre.org
Dear Colleagues,
We are honored to invite you to the Single Topic Conference on Non-responders that will
be held between 22nd – 24th September, 2016 at Hilton Bosphorus Hotel in İstanbul, Turkey.
Such problems as the exposure of patients to cirrhosis of the liver, and its complications due to
the unresponsiveness of chronic hepatitis B, C, and delta infections, to the current treatments;
the development of hepatocellular carcinoma; and recurrence of infections following liver
transplantation continue to be challenging issues in today’s world. New research with respect to
patients with chronic hepatitis and who do not respond, specifically to the treatments specified
in the treatment guidelines, will be presented, and interactive discussions will be held with the
world’s opinion leaders on hepatology.
At the same time, the similarities and differences (if any) in terms of treatment between the East
and the West will be debated. In particular, the steadily increasing trends in cirrhosis of the liver
and hepatocellular cancer rates dependent on the unresponsiveness of the hepatitis C virus,
between 2020 and 2030, will be confronted. For this reason, the treatment of compensated and/
or decompensated cirrhosis of the liver being unresponsive or partially responsive to previous
treatments or those developing dependent on relapses following treatment will continue to be
a globally significant health problem.
Following the discovery of the Neolithic settlement during excavations in Yenikapı (the ancient
port of Theodosius) it is now understood that the origins of Istanbul date back at least 8,500
years. The city of Istanbul was known as Byzantium by the Greeks in 700 BCE; as Constantinople
it was the capital of the Roman and Eastern Roman Empires. Following the conquest of the city
by the Ottoman Empire in 1453, the city remained the capital of the Ottoman Empire for almost
five centuries, and was known to the Turks as Istanbul.
Among the most important monuments defining the culture and identity of the city are, the
Hippodrome, the Basilica Cistern and the Column of Constantine date, which date from Roman
times. Then there is the Galata Tower but by the Genoese, and of course, Haghia Sophia, which
still stands as the most important testament to the Byzantine age in the world after 1500 years.
Then there are the Ottoman buildings, such as the Topkapı Palace, for centuries the residence
of the Ottoman sultans and the administrative center, together with more than 80 museums
and 9 other Ottoman palaces. The Sultanahmet Mosque and Süleymaniye Mosque and superb
examples of Ottoman religious architecture and the Grand Bazaar and Spice Market (Kapalıçarşı
and Mısır Çarşısı), both still going strong today, continue the commercial tradition, for which
Istanbul is so famous.
Istanbul’s cultural heritage has given the city international importance: in 2010 it was the
European Capital of Culture and it is now included in the UNESCO World Heritage List. With
its historical and natural beauties, bridges and underwater tunnel connecting the Asian and
European continents, Istanbul shines like pearl on the Bosphorus.
Its ancient history and five centuries as the capital of the Ottoman Empire mean that alongside
its own cultural wealth and culinary diversity, Istanbul embraces the illustrious cuisines of Asia,
Europe and Africa. Turkish cuisine, now only second to Chinese in terms of popularity, celebrates
its huge range of dishes, amazingly there are more than 400 varieties of dessert alone, and all of
them are distinctive and delicious.
We would like to conclude by saying how we will be pleased to welcome you in Istanbul, offering
you the finest Traditional Ottoman Hospitality on the occasion of this scientifically rich program.
Prof. A. Kadir DÖKMECİ, MD.
Honorary President
Prof. Necati ÖRMECİ, MD.
Congress President
Prof. Hasan ÖZKAN, MD.
Congress Secretary General
3
SUPPORTING ORGANIZATIONS
Turkish Association of Hepato – Bilio Pancreatology (HEBİPA)
President: Abdulkadir DÖKMECİ
Gastroenterological Surgery Association
President: Birol BOSTANCI
Euroasian Gastroenterological Association
President: Hasan ÖZKAN
Gastrointestinal Motility Society
President: Selahattin ÜNAL
United European Gastroenterology Association
President: Michael MANNS
Gastrointestinal Endoscopy Association
President: İrfan KORUK
Viral Hepatitis Association
President: Fehmi TABAK
Raising Drug Use Awareness and Rational Drug Use Association
President: İsmail BALIK
Probiotics and Prebiotics Association
President: Tarkan KARAKAN
İstanbul Gastroenterological Surgery Association
President: Birol BOSTANCI
Infectious Diseases and Clinical Microbiology Specialty Society of Turkey
President: İftihar KÖKSAL
Specialty Association of Clinical Microbiology
President: Burçin ŞENER
Gastrointestinal Endoscopy Nurses and Health Technicians Association
President: Türkan AKYILDIZ
4
TOPICS
Chronic Hepatitis B
Chronic Hepatitis C
Chronic Hepatitis D
Nash
Autoimmune Liver Diseases
Metabolic Liver Diseases
Hepatic Vascular Diseases
Hepatocellular Carcinoma
Non - Response in Liver - Related Complications
Alcoholic Liver Diseases
Special Populations
Transplantation
Acute on Chronic Liver Failure
5
COMMITTEES
APASL STEERING COMMITTEE
Chairman
Shiv K SARIN
President
Jinlin HOU
Immediate Past President
Osamu YOKOSUKA
President Elect
Barjesh C. SHARMA
PAST PRESIDENTS
Darrell CRAWFORD
A.Kadir DOKMECI
Ji-Dong JIA
Jia-Horng KAO
George LAU
Laurentius A. LESMANA
Masao OMATA
Teerha PIRATVISUTH
Jose SOLLANO
Dong Jin SUH
*Names are sorted by last name in alphabetical order.
6
COMMITTEES
EXECUTIVE COUNCIL
LOCAL ORGANIZING COMMITTEE
Shahab ABID
Deepak. N. AMARAPURKAR
Oidov BAATARKHUU
Wan-Long CHUANG
Ian Homer Y. CUA
Alaa IBRAHIM
Changmin KIM
Cosmas Rinaldi A. LESMANA
Necati ÖRMECİ
Alexander THOMPSON
Lai WEI
Hiroshi YATSUHASHI
Emin ALTIPARMAK
Sait BAĞCI
İsmail BALIK
Şahin ÇOBAN
Bülent DEĞERTEKİN
Osman ERSOY
Rahmet GÜNER
Mehmet İBİŞ
Murat KEKİLLİ
Seyfettin KÖKLÜ
Ersan ÖZASLAN
Metin UZMAN
PRESIDENTS OF THE CONGRESS
President of the Congress
Necati ÖRMECİ
Honorary President
A.Kadir DÖKMECİ
Congress Secretary General
Hasan ÖZKAN
*Names are sorted by last name in alphabetical
order.
7
SCIENTIFIC COMMITTEE
Ulus Salih AKARCA
Meral AKDOĞAN
Murat ALADAĞ
Fatih ALBAYRAK
Mehmet ARSLAN
Celal AYAZ
Bilgehan AYGEN
Kadir BAHAR
Ömer BAŞAR
Ahmet BEKTAŞ
Hürrem BODUR
Arif Mansur COŞAR
Ahmet DANALIOĞLU
Ali DEMİR
Mehmet DEMİR
Gülbin DÖKMECİ
Fuat EKİZ
Hakan ERDEM
Vedat GÖRAL
Sefa GÜLİTER
Selim GÜREL
Kenan HIZEL
Sadettin HÜLAGÜ
Abdurrahman KADAYIFÇI
Cem KALAYCI
Bülent KANTARÇEKEN
Zeki KARASU
Mesut AKARSU
Hikmet AKKIZ
Hakan ALAGÖZLÜ
Akif ALTINBAŞ
Hilmi ATASEVEN
Selim AYDEMİR
Necip AYTUĞ
İbrahim Halil BAHÇECİOĞLU
Metin BAŞARANOĞLU
Fatih BEŞIŞIK
Hakan BOZKAYA
M. Kemal ÇELEN
8
Halil DEĞERTEKİN
Kadir DEMİR
Ümit Bilge DOĞAN
Hakan DURSUN
Elife ERARSLAN
Galip ERSÖZ
Can GÖNEN
Yunus GÜRBÜZ
Kadri GÜVEN
Salih HOŞOĞLU
Ramazan İDİLMAN
Ayhan Gazi KALAYCI
Münci KALAYOĞLU
Çetin KARACA
Muhsin KAYA
Ertuğrul KAYAÇETİN
Mehmet KORUK
İftihar KÖKSAL
Yaşar NAZLIGÜL
İbrahim Koral ÖNAL
Reşat ÖZARAS
Birol ÖZER
Tuğrul PÜRNAK
Orhan SEZGİN
Mehmet SÖKMEN
Mustafa SÜNBÜL
Hakan ŞENTÜRK
Fehmi TABAK
İlyas TUNCER
Necla TÜLEK
Ediz TÜTÜNCÜ
Belkıs ÜNSAL
Fahri YAKARYILMAZ
M. Hadi YAŞA
Beytullah YILDIRIM
Ömer YILMAZ
Cihan YURDAYDIN
Osman YÜKSEL
Orhan KOCAMAN
İrfan KORUK
Işılay NADİR
Nihat OKÇU
Ayşegül ÖZAKYOL
Osman Cavit ÖZDOĞAN
Orhan ÖZGÜR
Cemil SAVAŞ
Abdullah SONSUZ
İnci SÜLEYMANLAR
Ebubekir ŞENATEŞ
Halis ŞİMŞEK
Ömer TOPALAK
Murat TUNCER
Cansel TÜRKAY
Celal ULAŞOĞLU
Raşit Vural YAĞCI
Kendal YALÇIN
Necati YENİCE
Nevin YILMAZ
Yusuf YILMAZ
Mehmet YÜCESOY
*Names are sorted by last
name in alphabetical order.
TENTATIVE COURSE PROGRAMME
22 September 2016
Murat ALADAG
Ahmet GURAKAR
A. Kadir DOKMECI
VIRAL HEPATITIS:
IMMUNEPATHOGENESIS,
DIAGNOSIS AND
MANAGEMENT
Halis SIMSEK
Ramazan IDILMAN
HALL C
COURSE - 3
APASL SINGLE
TOPIC LIVER
TRANSPLANTATION
COURSE
HALL B
COURSE - 2
COURSE - 1
HALL A
APASL - SINGLE
TOPIC ENDOSCOPY
COURSE
Emrah ALPER
SESSION 1:
SESSION 1:
SESSION 1:
Münci KALAYOGLU
Meral AKDOGAN
Murat Taner GULSEN
Gyongyi SZABO
Halis SİMSEK
Ramazan IDILMAN
Reşit MISTIK
Hitoshi MARUYAMA
Sadettin HULAGU
İbrahim Halil
BAHCECIOGLU
13:00
13:20
Patient Selection and
Preparation for Liver
Transplantation
Meral AKDOGAN
13:00
13:20
Immunity and
Inflammation in Chronic
HCV Infection
Gyongyi SZABO
13:00
13:20
Endoscopic
Management of
Eosophageal Varices
Abdurrahman
KADAYIFCI
13:20
13:40
Living Donor Liver
Transplantation in Portal
Vein Trombosis
Sezai YILMAZ
13:20
13:40
Non-invasive
Assessment of Liver
Fibrosis
Levent DOGANAY
13:20
13:40
Endoscopic
Management of
Gastric Varices
Hiroshi
YATSUHASHI
13:40
14:00
LDLT or DDLT in Acute
Fulminant Liver Failure
Cüneyt KAYAALP
13:40
14:00
Histopathological
Diagnosis of Chronic
Hepatitis B and C
Cenk SOKMENSUER
13:40
14:00
Therapy of Portal
Cholangiopathy
Hitoshi MARUYAMA
14:00
14:20
LDLT or DDLT in
Hepatocellular
Carcinoma
Deniz BALCI
14:00
14:20
New Imaging Modalities
for the Diagnosis of
Liver Diseases
Suna OZHAN OKTAR
14:00
14:20
TIPS: Indication,
Contraindication the
Impact of TIPS for
Portal Hypertension
Ahmet Baran ÖNAL
14:20
14:40
Coffee Break
9
TENTATIVE COURSE PROGRAMME
22 September 2016
HALL A
HALL B
HALL C
SESSION 2:
SESSION 2: TREATMENT OF
CHRONIC HEPATITIS B
SESSION 2: MANAGEMENT
OF BILIARY DISEASES
Yalçın POLAT
Murat ALADAG
Murat KIYICI
Gamal SHIHA
Hasan OZKAN
Osman Cavit OZDOGAN
Fehmi TABAK
Toshio TSUYUGUCHI
Billur CANBAKAN
Cemil SAVAS
Ahmet Faruk AGAN
14:40
15:00
Immunsupression in
Liver Transplantation
Wasim JAFRI
15:00
15:20
Pre-post Transplantation
15:00
HBV Treatment
15:20
Ramazan IDILMAN
14:40
15:00
Drug Targets on Viral
Replication in the New
Insight
Gyongyi SZABO
HBeAg (+) CHB: Treat
with IFN or with Nas
Jia-Horng KAO
14:40
15:00
Endoscopic
Approaches in
Primary Sclerosing
Cholangitis
Orhan TARCIN
15:00
15:20
Endoscopic
Treatment of Biliary
Strictures After Liver
Transplantation
Yaşar TUNA
15:20
15:40
Management of HCV in
Developing Countries
Hakan LEBLEBICIOGLU
15:20
15:40
HBeAg (-) CHB: Treat
with IFN or with Nas
Dinç DINCER
15:20
15:40
Endoscopic
Treatment of
Metastatic
Cholestatic Liver
Disease
Toshio TSUYUGUCHI
15:40
16:00
HCC: Resection or Liver
Transplantation
Chul Soo AHN
15:40
16:00
HBeAg (-) CHB: Therapy
and Stopping Rules
Lai WEI
15:40
16:00
Percutaneous
Treatment for
Malingnant Strictures
Murat KEKILLI
16:00
16:20
Discussion
16:00
16:20
Discussion
16:00
16:20
Discussion
16:20
16:40
10
Coffee Break
TENTATIVE COURSE PROGRAMME
22 September 2016
HALL A
HALL B
HALL C
SESSION 3:
SESSION 3: TREATMENT OF
CHRONIC HEAPTITIS C
SESSION 3:
ENDOSONOGRAPHY IN
HEPATOBILIARY DISEASES
Vivek KUMBHARI
Ali Emre TUZUN
Bülent ODEMIS
Kadir AKSOZ
Masao OMATA
Bülent YILDIRIM
Şükran KOSE
Can GONEN
Emrah ALPER
Ahmet BEKTAS
Cem KALAYCI
16:40
17:00
Post Transplant Bile
Duct Problems
Vivek KUMBHARI
16:40
17:00
Drugs for the Treatment
of HCV: Classification,
Sites of Action
Ayşe AYTAMAN
16:40
17:00
Efficacy of EUS in
Liver Diseases
Sinan AKAY
17:00
17:20
Diagnosis and
Palliative Treatment
in Cholangiocarcinomas
Deniz GUNEY
DUMAN
17:00
17:20
Post Transplant ERCP in
Difficult Cases
Murat HARPUTOGLU
17:00
17:20
Treatment of HCV in
the Real Word: Optimal
Regimes to Offer Within
the Cascade Approach
Nurdan TOZUN
17:20
17:40
Post Transplant PTC
Ramazan KUTLU
17:20
17:40
The Treatment of HCV,
Genotype 3
Saeed HAMID
17:20
17:40
What is the Role of
EUS in the Treatment
of Gallstones
Emrah ALPER
17:40
18:00
Prediction of Acute and
the Chronic Rejection of
Tranplanted Liver
Murat AKYILDIZ
17:40
18:00
The Treatment of
Genotype 4, 5 and 6
Alaa IBRAHIM
17:40
18:00
New Horizons in EUS
Hakan SENTUK
18:00
18:20
Discussion
18:00
18:20
Discussion
18:00
18:20
Discussion
Osman YÜKSEL
Sebnem GURSOY
18:20
18:40
18:20
18:40
Can We Stop Nas in
Patients with Chronic
Hepatitis B?
Alper YURCI
18:20
18:40
Where are We Now
in Cholangioscopy?
Toshio
TSUYUGUCHI
18:40
18:50
Discussion
18:40
18:50
Discussion
18:40
18:50
Discussion
11
12
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
HALL C
CHRONIC VIRAL HEPATITIS
METABOLIC LIVER DISEASE IN
THE PEDIATRIC PATIENTS
AUTOIMMUNE
HETATITIS
Jia- Horng KAO
Hikmet AKKIZ
Yusuf UZUN
Georgios LOUDIANOS
Aydan KANSU
Buket DALGIC
Çiğdem ARIKAN
Joest DRENTS
Erol AVSAR
Ömer TOPALAK
Ender ELLIDOKUZ
08:30
08:50
Why Non-Responder?
(Definition)
Jia-Horng KAO
08:30
08:50
Is it Increasing or Are
We Doing a Better Job?
Fatih EZGU
08:30
08:50
How to Diagnose
the Primary Biliary
Cirrhosis
Mehmet YALNIZ
08:50
09:10
What's the Molecular
Mechanism of
Non-Response?
Gyongi SZABO
08:50
09:10
New Insight of Wilson
Disease
Georgios LOUDIANOS
08:50
09:10
Primary Biliary
Cirrhosis Treatment;
Beyond UDCA
Mevlut BASKOL
09:10
09:30
Prediction and
Diagnose of
Non-Response?
Shahab ABID
09:10
09:30
Alpha-1 Antitrypsin
Deficiency
Nedim HADZIC
09:10
09:30
How to Diagnose of
Primary Sclerosing
Cholangitis
Ebubekir SENATES
09:30
09:50
Epidemiology and
Burden of
Non-Response in the
World
Simten MALHAN
09:30
09:50
Liver Storage Diseases
Figen GURAKAN
09:30
09:50
Treatment of Primary
Biliary Cirrhosis.
What is New in the
World?
Cumhur DULGER
09:50
10:00
Discussion
09:50
10:00
Discussion
09:50
10:00
Discussion
10:00
10:30
Coffee Break
13
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
HALL C
CHRONIC
HEPATITIS B
NASH
FREE
PAPERS
Wasim JAFRI
Abdullah SONSUZ
Yücel USTUNDAG
Salih HOSOGLU
Zaigam ABBAS
Rauf AGAYEV
Ömer SENTURK
Murat KEKILLI
Hakan LEBLEBICIOGLU
Hakan DURSUN
Mustafa SUNBUL
Elife ERARSLAN
10:30
10:50
The Impact of
Non-Response On The
Management of Chronic
Hbv Infection
Hikmet AKKIZ
10:30
10:50
Definition of
Non-Response in NASH.
Zaigam ABBAS
10:30
10:50
10:50
11:10
What Kind of Options
Do We Have? (Current
Management)
Saeed HAMID
10:50
11:10
Two "Atypical" Forms of
Nonalcoholic Fatty Liver
Disease: NAFLD Without
Metabolic Syndrome
and Lean NAFLD
Yusuf YILMAZ
10:50
11:10
11:10
11:30
New Horizons For The
Treatment Of Chronic
Hepatitis B
George LAU
11:10
11:30
NAFLD in Non Obese
People
Metin BASARANOGLU
11:10
11:30
11:30
11:50
Hbe Ag
Non-Seroconverter On
Long Term Anti Viral
Therapy
Deepak AMARAPURKAR
11:30
11:50
How to Treat NAFLD
Ahmet UYGUN
11:30
11:50
11:50
12:00
Discussion
11:50
12:00
Discussion
11:50
12:00
12:00
12:30
Opening Ceremony
12:30
13:00
A.Kadir DOKMECI
13:00
14:00
14
ART LECTURE
The Impact of RAV on The Treatment of Chronic Hepatitis C Masao OMATA
GILEAD SATELLITE SYMPOSIUM & LUNCH
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
HALL C
CHRONIC
HEPATITIS D
THE CHALLENGES IN HEPATATIC
VASCULARY DISEASES
AUTOIMMUNE HEPATIT,
HCC AND BLEEDING
Mario RIZETTO
Halil DEGERTEKIN
Yıldıran SONGUR
Mustafa Kemal CELEN
Jose SOLLANO
Emin ALTIPARMAK
Hakkı POLAT
Hasmik GHAZINYAN
Mehmet YUCESOY
Enver DOLAR
Mehmet SOKMEN
Hüseyin ATASEVEN
14:00
14:20
Retreatment With
Interferon In Non
Responders.
Fulya GUNSAR
14:00
14:20
Difficulties in Treatment
of Budd Chiari Disease
Jose SOLLANO
14:00
14:20
Steroid Refractory
Autoimmune
Hepatitis
Goktug SIRIN
14:20
14:40
Longer Treatment With
14:20
Interferon As An Option.
14:40
Cihan YURDAYDIN
Therapeutic Decision in
Portal Vein Thrombosis
Vedat GORAL
14:20
14:40
Autoimmune
Hepatitis: Treatment
and Outcomes
Ian Homer Y. CUA
14:40
15:00
Bridging And
Downstaging
Treatments in
Patients On the
Waiting List For
Transplantation
Sadık BILGIC
14:40
15:00
The Treatment of
Hepatic Sinusoidal
Obstruction Syndrome.
Alpaslan TANOGLU
15:00
15:20
New Treatment
Modalities In
Non-Responders
Mario RIZETTO
15:00
15:20
Interventional Radiology
in Hepatic Vasculary
Diseases
Sadık BILGIC
15:00
15:20
Interventional
Endoscopic
Examination in Liver
Cirrhosis
Fatih ASLAN
15:20
15:30
Discussion
15:20
15:30
Discussion
15:20
15:30
Discussion
14:40
15:00
The Treatment Of
Co-Infection With Delta
Reşat OZARAS
15:30
16:00
Coffee Break
16:00
17:00
ABBVIE SATELLITE SYMPOSIUM
15
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
SPECIAL POPULATIONS
IN CHB
ALCOHOLIC LIVER
DISEASES
Tarık ASSELAH
M. Hadi YASA
Kendal YALCIN
Gülbanu CANBALOGLU ERKAN
Rino GANI
Ayşegül OZAKYOL
Yaşar NAZLIGUL
Fatih ALBAYRAK
HALL C
HCV
Belkıs UNSAL
İsmail BALIK
Bilgehan AYGEN
Neşe IMERYUZ
17:00
17:20
Pregnancy and
Lactation
Nevin YILMAZ
17:00
17:20
What To Do in
Non-Responders
Of Acute Alcoholic
Hepatitis
Dong Joon KIM
17:00
17:20
Non Response
During DAAs Era
Lai WEI
17:20
17:40
Immunocompromised
Patients
Bülent DEGERTEKIN
17:20
17:40
Treatment For Chronic
Alcoholic Cholestatic
Disease
Yusuf YAZGAN
17:20
17:40
The Treatment of
HCV in Special
Populations
Necati ORMECI
17:40
18:00
Factors Associated
With
Non-Responders of
Hepatitis B,C and
Delta, in Pakistan.
Shahab ABID
17:40
18:00
Chronic Renal Failure
Tevfik ECDER
17:40
18:00
Challenges In Liver
Transplantation of
Alcoholic Cirrhosis
Diana A. PAYAWAL
18:00
18:20
Co-infection
Tarık ASSELAH
18:00
18:20
Imaging and New
Treatment Modality of
HCC (CCC)
Shuichiro SHIINA
18:00
18:20
The Treatments With
Inhibitors of Cell
Entrance in Chronic
HCV Infection
Che COLPITTS
18:20
18:30
Discussion
18:20
18:30
Discussion
18:20
18:30
Discussion
Mohammed Hossein SOMI
18:30
18:50
16
A Novel Immune
Therapy for Chronic
Hepatitis B: Relevance
to Reduction of NonResponder of Present
Therapeutic Options
Fazle AKBAR
Enver ZEREM
18:30
18:50
18:30
18:50
Hepathopulmonary
and
Porthopulmonary
Syndromes,
Diagnoses and
Treatments
Ahmet GURAKAR
17
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
CHRONIC
HEPATITIS C
HCC
FREE
PAPERS
Tarık ASSELAH
Necati ORMECI
İftihar KOKSAL
Macit GULTEN
Shuichiro SHIINA
Bülent KANTARCEKEN
Ömer SENTURK
Dursun Kadir BAHAR
Oidov BAATATKHUU
Necati YENICE
Fuat EKIZ
İlker TURAN
08:30
08:50
Primary Antiviral
Resistance; Is It Clinically
Important
Tarık ASSELAH
08:30
08:50
Best Treatment
Option in HCC;
Ablation, Resection
or Transplantation?
Shuichiro SHIINA
08:30
08:50
08:50
09:10
Current Treatment of
CHC in Terms of
Guide-lines
Ayşe AYTAMAN
08:50
09:10
Predictions of
Recurrence and
Prevention of
Recurrence, How?
Hikmet AKKIZ
08:50
09:10
09:10
09:30
Management of Direct
Acting Antivirals
Treatment Failure
Wasim JAFRI
09:10
09:30
Management of
Patients with Recurrent
Hepatocellular
Carcinoma
Salim DEMIRCI
09:10
09:30
09:30
09:50
The Situation of IFN
Free Treatment in
Chronic HCV
Osamu YOKOSUKA
09:30
09:50
When the Palliative
Chemotherapy is an
Option?
Şuayib YALCIN
09:30
09:50
09:50
10:00
Discussion
09:50
10:00
Discussion
09:50
10:00
10:00
10:30
18
Coffee Break
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
ACUTE ON CHRONIC LIVER
FAILURE
AUTOIMMUNE LIVER
DISEASES
FREE
PAPERS
Shiv SARIN
Sabahattin KAYMAKOGLU
Mehmet IBIS
Osman YUKSEL
Joest DRENTS
Sait BAGCI
Cemil SAVAS
Nihat OKCU
Salimur RAHMAN
Metin UZMAN
Beytullah YILDIRIM
Birol BAYSAL
10:30
10:50
Definition of ACLF
A.Kadir DOKMECI
10:30
10:50
Treatment of
Autoimmune Hepatitis
Together with Chronic
HBV or HCV
Joest DRENTS
10:50
11:10
Acute Insult of ACLF
Mamun Al MAHTAB
10:50
11:10
The Treatment of Acute
Fulminant Autoimmune
Hepatitis
Gamal SHIHA
10:50
11:10
11:10
11:30
Acute Kidney Injury in
ACLF
Yogesh CHAWLA
11:10
11:30
The treatment of
Autoimmune Liver
Cirrhosis
Ahmet GURAKAR
11:10
11:30
11:30
11:50
Therapy of ACLF
Shiv SARIN
11:30
11:50
The Non-response in
Overlap and Outlier
Syndromes
Ömer OZBAKIR
11:30
11:50
11:50
12:00
Discussion
11:50
12:00
Discussion
11:50
12:00
10:30
10:50
Discussion
12:00
12:30
CONFERENCE:
Hasan OZKAN- Shiv SARIN
12:30
13:00
Okuda Lectures: Necati ORMECI Stemcell Transplantation: Stephen STROM
13:00
14:00
LUNCH & SATELLITE SYMPOSIUM
19
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
TRANSPLANTATION
NON-RESPONSE IN LIVERRELATED COMPLICATIONS
VIRAL HEPATITIS
B, C, D
Alaa IBRAHIM
Murat ALADAG
Mamun Al MAHTAB
Çetin KARACA
Barjesh C SHARMA
Mehmet ARSLAN
Filiz AKYUZ
Ali DEMIR
Shahab ABID
Celal ULASOGLU
Rahmet GUNER
Kenan HIZEL
14:00
14:20
Pre and Post Liver Tx
HBV Treatment ; HBIG
Prophylaxis
Tatsua KANDA
14:00
14:20
The Treatment of
HBV in Special
Populations
Meltem ERGUN
14:20
14:40
Management of
Cirrhotic Refracter
Ascitis
İnci SULEYMANLAR
14:20
14:40
The Treatment
of HBV in
Haematologic
Disorders
George LAU
14:40
15:00
Minimal Hepatic
Encephalopathy, Shoud
We treat or Not
Barjesh C SHARMA
14:40
15:00
Management of
HBV in Pregnancy
Yasemin BALABAN
15:00
15:20
Management of Pre
and Post Transplanted
Patients with Chronic
HCV Ahmet GURAKAR
15:00
15:20
Approach to Patient
with Resistant
Hyponatremia
Seyfettin KOKLU
15:00
15:20
The Clinical
Utility of HBsAg
Quantification in the
Natural Course of
Chronic Hepatitis B
Hasan OZKAN
15:20
15:30
Discussion
15:20
15:30
Discussion
15:20
15:30
Discussion
14:00
14:20
Management of
Cirrhotic Ascites
Mehmet ARHAN
14:20
14:40
Treatment of Rejection
in Patients with Steroid
Resistant
Chandan KUMAR
14:40
15:00
Biliary Complications in
Post-Transplant Patients
İrfan KORUK
15:30
16:00
Coffee Break
16:00
17:00
SATELLITE SYMPOSIUM
20
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
PRESIDENT’S
CHOICES
CASE PRESENTATIONS
THE TREATMENT OF
CIRRHOSIS COMPLICATIONS
Nihat OKCU
Necla TULEK
Arif Mansur COSAR
Altuğ SENOL
M.Kürşat TURKDOGAN
Celal AYAZ
Ramazan KURT
Ahmet UYANIKOGLU
Kadri GUVEN
Cem KOCKAR
Ali Tüzün INCE
Hakan YUCEYAR
17:00
17:20
17:00
17:20
17:00
17:20
The Non-response
to Treatment
with Terlipressin
and Albumin
in Hepatorenal
Syndrome
Salimur RAHMAN
17:20
17:40
17:20
17:40
17:20
17:40
The Non-response to
Vasoactive Therapy
in Variceal Bleeding
Sahin COBAN
17:40
18:00
17:40
18:00
17:40
18:00
The Treatment of
Spontan Bacterial
Peritonitis
Hakan ERDEM
18:00
18:20
The Treatment of
Portal Hypertensive
Gastroenteropathy in
Liver Cirrhosis
Tuğrul PURNAK
18:20
18:30
Discussion
18:30
19:10
CONFERENCE:
How Can We Predict
Future About HCV
Homie RAZAVI
18:00
18:20
18:20
18:30
18:00
18:20
Discussion
18:20
18:30
Discussion
Laurentius A. LESMANA
18:30
19:10
CONFERENCE:
Acute Liver Failure How
to Treat
Ayse AYTAMAN
Wan-Long CHUANG
18:30
19:10
Diagnostic Approach
for Non-Alcoholic Fatty
Liver Disease
Amna Subhan BUTT
Laurentius A. LESMANA
Muammer KARA
21
REGISTRATION & ACCOMMODATION
EARLY BIRD REGISTRATION
(Before 1st July 2016)
LATE REGISTRATION
(After 1st July 2016)
ON SITE
REGISTRATION
Apasl Member
600 $
650 $
700 $
Specialist
650 $
700 $
750 $
Assistant / Student
250 $
300 $
350 $
Abstract Presenter
500 $
550 $
600 $
Company Representative
650 $
700 $
750 $
EARLY BIRD REGISTRATION
(Before 1st July 2016)
LATE REGISTRATION
(After 1st July 2016)
REGISTRATION TYPE
Vat is included in above fees.
Services included in the registration fee; • Participation to the scientific sessions • Congress documents
(Congress Bag, Program Booklet, Abstract Booklet, Certificate of Attendance, Name Badge)
HOTEL NAME ( 1 NIGHT )
Single
Room
Double
Room
Single
Room
Double
Room
HILTON HOTEL (Venue)
250 $
150 $
270 $
170 $
POINT HOTEL (Walking Distance: 600 m)
220 $
135 $
240 $
155 $
KONAK HOTEL (Walking Distance: 350 m)
200 $
125 $
220 $
145 $
CROWNE PLAZA HOTEL (Walking Distance: 800 m)
200 $
125 $
220 $
145 $
ARTS HOTEL BOSPHORUS (Walking Distance: 600 m)
190 $
120 $
210 $
140 $
RAMADA ŞİŞLİ HOTEL (Walking Distance: 1,1 km)
190 $
120 $
210 $
140 $
TITANIC TAKSİM HOTEL (Walking Distance: 800 m)
180 $
115 $
200 $
135 $
AVANTGARDE TAKSİM HOTEL (Walking Distance: 950 m)
180 $
115 $
200 $
135 $
HOLIDAY INN ŞİŞLİ HOTEL (Walking Distance: 1,7 km)
170 $
110 $
190 $
130 $
GREEN PARK TAKSİM HOTEL (Walking Distance: 1,2 km)
140 $
95 $
160 $
115 $
Vat is included in above fees.
Services included in the accommodation fee; • 1 Night Bed & Breakfast Accommodation
EVENT TYPE
Gala Dinner (23rd September)
Vat is included in above fees.
70 $
TRANSFER TYPE
Double Way Transfer (Atatürk Airport)
100 $
Double Way Transfer (Sabiha Gökçen Airport)
200 $
Vat is included in above fees. • Transfer prices mentioned above are collective transportation fees.
Participants should contact FTS Congress for the private transfer requests.
22
GENERAL INFORMATION
Date and Place
APASL Single Topic Conference will be held between the dates of 22nd- 24th September
2016 at Hilton Bosphorus Hotel.
Congress Venue
Hilton İstanbul Bosphorus Hotel
Address: Cumhuriyet Cad. 34367 Harbiye - İstanbul
Phone: 0212 315 60 00
Conference Language
Conference official language is English.
Invitation Letter
Participants need to obtain permission from their respective institutions to the congress
in accordance with the demands of the letter of invitation will be sent to participants.
Badge
Name badges will be given to all registered participants and companies. It is kindly
requested to wear name badges during all academic and social activities in order to
ensure good organization of the congress.
Certificate of Attendance
Certificates of participation will be delivered to academic program participants at the last
day of the congress.
Stand and Exhibition Areas
During the Conference, the pharmaceutical industry, related device companies and book
stands can find large area to present their productions. In order to visit exhibition area,
you must be participant of the Conference.
Payments
Payments will be made by TL, Dollar and Bank transfer or by credit card. Participants,
who will make their payments in TL, are required to pay effective sales exchange rate of
the Central Bank in the day of payment.
Cancellation Policy
The detailed information about cancellation policy is expressed in accommodationregistration page, and also there will not be different practice.
23
24